A. Kazimi | executive |
Todd Anthony | executive |
John Hamm | executive |
Good afternoon, and welcome to Cumberland Pharmaceuticals First Quarter 2024 Financial Report and Company Update. This call is being recorded at Cumberland's request and will be archived on the company's website for 1 year from today's date.
I would now like to turn it over to Molly Aggas, Account Supervisor at the Dalton Agency, who handles Cumberland's Communications.
Molly, please go ahead.
Hello, everyone.